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Abstract
Inspired by the pioneering work of Rubin (1978), we employ the potential outcomes frame-
work to develop a finite-population Bayesian causal inference framework for randomized con-
trolled 2K factorial designs with binary outcomes, which are common in medical research. As
demonstrated by simulated and empirical examples, the proposed framework corrects the well-
known variance over-estimation issue of the classic “Neymanian” inference framework, under
various settings.
Keywords: Factorial effect; Frequentist-Bayes reconciliation; potential outcome; randomization-
based inference; sensitivity analysis
1. INTRODUCTION
Medical researchers (e.g. Chalmers et al., 1955; Hennekens and Eberlein, 1985; Stampfer et al.,
1985; Eisenhauer et al., 1994; Campeau et al., 1997; Rapola et al., 1997; Franke et al., 2000; Ayles
et al., 2008; Greimel et al., 2011; Manson et al., 2012; James et al., 2013) have a long history
of employing randomized controlled 2K factorial designs to simultaneously evaluate the causal
effects of multiple two-level treatment factors on binary outcomes. To conduct causal inference
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on randomized controlled 2K factorial designs, Dasgupta et al. (2015) proposed a randomization-
based framework based on potential outcomes (Neyman, 1923; Rubin, 1974, 1990). Unlike model-
based approaches (e.g., Simon and Freedman, 1997), the “Neymanian” causal inference framework
proposed by Dasgupta et al. (2015) relies only on the randomization of the treatment assignment,
which is often considered the “gold standard for causal inference” (Rubin, 2008). The Neymanian
framework possesses some conceptual, theoretical and practical appeals. For example, as pointed
out by several researchers (e.g., Miller, 2006), in some randomized experiments the participants
are not a random sample from a hypothetical super-population. In such cases, finite-population
analyses by the Neymanian framework might be more interpretable.
Despite the aforementioned advantages of the Neymanian causal inference framework, a long-
standing challenge it faces is the over-estimation of the sampling variance of the randomization-
based causal estimate, as mentioned by Aronow et al. (2014). A possible solution of this challenge
is the finite-population Bayesian inference framework by Rubin (1978), which uniquely combined
the strengths of both the classic Neymanian and the classic Bayesian methodologies, by assuming
that the potential outcomes are sampled from a hypothetical super-population, while retaining the
finite-population causal effects as the inferential end-points. Realizing this salient feature, in an
illuminating paper Ding and Dasgupta (2016) developed a finite-population Bayesian framework
to analyze completely randomized treatment-control studies (i.e., 21 factorial designs) with binary
outcomes, and showed that it indeed dominated the classic Neymanian approach. Inspired by their
work, in this paper we extend Ding and Dasgupta (2016)’s finite-population Bayesian framework
to general 2K factorial designs.
The remainder of the paper is organized as follows. Section 2 reviews the Neymanian inference
framework for 2K factorial designs with binary outcomes. Section 3 developed a finite-population
Bayesian inference framework for 2K factorial designs, by first proposing an imputation model
under the assumption of independent potential outcomes, and then conducting sensitivity analysis
for when the independence assumption is violated. Sections 4 and 5 presented several simulated
and empirical examples to demonstrate the proposed Bayesian methodology. Section 6 concludes
and discusses future directions. We relegate all proofs and other technial details to the Appendix.
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2. NEYMANIAN INFERENCE
2.1. Factorial designs
In order to review the Neymanian causal inference framework for 2K factorial designs, we adapt
some materials from Lu (2016a,b). 2K factorial designs generally consist of K distinct treatment
factors with two-levels -1 and 1, resulting J = 2K treatment combinations z1, . . . ,zJ . To define
them, we construct the J × J model matrix H = (h0, . . . ,hJ−1) as follows (c.f. Wu and Hamada,
2009). First, let h0 = 1J . Second, for k = 1, . . . ,K, construct hk by letting its first 2
K−k entries
be -1, the next 2K−k entries be 1, and repeating 2k−1 times. Third, if K ≥ 2, order all subsets
of {1, . . . ,K} with at least two elements, first by cardinality and then lexicography. For k′ =
1, . . . J − 1−K, let σk′ be the k′th subset and hK+k′ =
∏
l∈σk′ hl, where “
∏
” stands for entry-wise
product.
The jth row of the sub-matrix (h1, . . . ,hK) is zj , for j = 1, . . . , J. For example, for K = 2,
H =

h0 h1 h2 h3
1 −1 −1 1
1 −1 1 −1
1 1 −1 −1
1 1 1 1

,
and the treatment combinations are z1 = (−1,−1), z2 = (−1, 1), z3 = (1,−1) and z4 = (1, 1),
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respectively. For K = 3,
H =

h0 h1 h2 h3 h4 h5 h6 h7
1 −1 −1 −1 1 1 1 −1
1 −1 −1 1 1 −1 −1 1
1 −1 1 −1 −1 1 −1 1
1 −1 1 1 −1 −1 1 −1
1 1 −1 −1 −1 −1 1 1
1 1 −1 1 −1 1 −1 −1
1 1 1 −1 1 −1 −1 −1
1 1 1 1 1 1 1 1

,
and the treatment combinations are z1 = (−1,−1,−1), z2 = (−1,−1, 1), z3 = (−1, 1,−1), z4 =
(−1, 1, 1), z5 = (1,−1,−1), z6 = (1,−1, 1), z7 = (1, 1,−1), and z8 = (1, 1, 1), respectively.
2.2. Potential outcomes and factorial effects
Utilizing the potential outcomes framework (Neyman, 1923; Rubin, 1974), Dasgupta et al. (2015)
advocated conducting randomization-based causal inference for 2K factorial designs with N ≥
2K+1 units, and invoke the Stable Unit Treatment Value Assumption (SUTVA, Rubin, 1980) that
there is only one version of the treatment and no interference among the units, for i = 1, . . . , N
we denote the potential outcome of unit i under treatment combination zj as Yi(zj), and Yi =
{Yi(z1), . . . , Yi(zJ)}′. For binary outcomes Yi(zj) ∈ {0, 1} (i = 1, . . . , N ; j = 1, . . . , J) :
1. Let
Dk1,...,kJ =
N∑
i=1
J∏
j=1
1{Yi(zj)=kj} (k1, . . . , kJ ∈ {0, 1}).
By definition
∑1
k1=0
. . .
∑1
kJ=0
Dk1,...,kJ = N. We characterize the potential outcomes using
D = (D0,0,...,0, D0,0,...,1, . . . , D1,1,...,0, D1,1,...,1)
′, where the indices are ordered binary represen-
tations of {0, . . . , J − 1};
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2. For all {j1, . . . , js} ⊂ {1, . . . , J}, let
Nj1,...,js =
N∑
i=1
1{Yi(zj1 )=1,...,Yi(zjs )=1} =
N∑
i=1
s∏
r=1
Yi(zjr).
Using the new notations, let the average potential outcome for zj is pj = Nj/N for j = 1, . . . , J,
and let p = (p1, . . . , pJ)
′. Therefore, for all units i = 1, . . . , N and all l = 1, . . . , J − 1, we define
the lth individual-level factorial effect for unit i as τil = 2
−(K−1)h′lYi. Consequently, we let the
population-level factorial effects be τ¯l = 2
−(K−1)h′lp.
2.3. Randomization-based inference
Let n1, . . . , nJ be positive constants such that
∑
nj = N. For all j = 1, . . . , J, we randomly
assign nj ≥ 2 units to zj . For all i = 1, . . . , N and all j = 1, . . . , J, let Wi(zj) = 1 if unit i is
assigned to zj , and zero otherwise, and let W = {Wi(zj)}ij denote the treatment assignment.
Therefore, the observed and missing potential outcomes for unit i are Y obsi =
∑J
j=1Wi(zj)Yi(zj)
and Y misi = {Yi(zj) : Wi(zj) = 0}, respectively. We denote the observed and missing outcomes for
the design as Y obs = (Y obs1 , . . . , Y
obs
N )
′ and Y mis = (Y mis1 , . . . ,Y misN ) respectively, and
nobsj =
N∑
i=1
Wi(zj)Yi(zj) =
∑
i:Wi(zj)=1
Y obsi (j = 1, . . . , J).
The average observed potential outcome for zj is pˆj = n
obs
j /nj , and denote pˆ = (pˆ1, . . . , pˆJ)
′.
Consequently, the randomization-based estimators for the factorial effects are
ˆ¯τl = 2
−(K−1)h′lpˆ (l = 1, . . . , J − 1). (1)
Motivated by the seminal work of Dasgupta et al. (2015), Lu (2016a,b) derived the sampling
variance of the estimator in (1) as
Var(ˆ¯τl) =
1
22(K−1)
J∑
j=1
S2j /nj −
1
N
S2(τ¯l), (2)
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where
S2j = (N − 1)−1
N∑
i=1
(
Yi(zj)− Y¯ (z1)
)2
=
N
N − 1pj(1− pj)
is the variance of potential outcomes for zj , and S
2(τ¯l) = (N − 1)−1
∑N
i=1(τil − τ¯l)2 is the variance
of the lth individual-level factorial effects. The “Neymanian” estimator for the sampling variance
(2) is obtained by substituting S2j with its unbiased estimate
s2j = (nj − 1)−1
N∑
i=1
Wi(zj){Y obsi − Y¯ obs(zj)}2 =
nj
nj − 1 pˆj(1− pˆj),
and substituting S2(τ¯l) with its lower bound 0:
V̂arNey(ˆ¯τl) = 2
−2(K−1)
J∑
j=1
s2j/nj = 2
−2(K−1)
J∑
j=1
pˆj(1− pˆj)
nj − 1 (3)
because S2(τ¯l) is not identifiable from the observed data. This estimator is “conservative” in the
sense that it over-estimates the true sampling variance on average by E
{
V̂arNey(ˆ¯τl)
}
− Var(ˆ¯τl) =
S2(τ¯l)/N. The bias is generally positive, unless strict additivity (Dasgupta et al., 2015; Ding and
Dasgupta, 2016; Ding, 2017) holds, i.e., τil = τi′l for all i 6= i′.
3. FINITE-POPULATION BAYESIAN ANALYSIS
3.1. Background
Motivated by the potential deficiencies of Neymanian inference, in this section we extend Rubin
(1978)’s finite-population Bayesian causal inference framework, which is employed by several re-
searchers for treatment-control studies (e.g., Hirano et al., 2000; Schwartz et al., 2011; Mattei et al.,
2013), to 2K factorial designs.
To ensure that the paper is self-contained, we briefly summarize Rubin (1978)’s general frame-
work (c.f. Imbens and Rubin, 2015) as follows (we use f(·) and f(·|·) as generic symbols for uncon-
ditional and conditional distributions, respectively):
1. Jointly model the (observed and missing) potential outcomes and treatment assignment by
f(Y obs,Y mis,W | Θ), and specify the prior distribution for the parameters f(Θ);
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2. Obtain the posterior distribution of the missing potential outcomes Y mis, conditioning on the
observed data Y obs, the treatment assignment W , and the parameters Θ :
f(Y mis | Y obs,W ,Θ) = f(Y
obs,Y mis |W ,Θ)∫
ymis f(Y
obs,ymis |W ,Θ)dymis ; (4)
3. Obtain the posterior distribution of the parameters Θ, conditioning on the missing potential
outcomes Y mis and the treatment assignment W :
f(Θ | Y obs,W ) =
f(Θ)
∫
ymis f(Y
obs,ymis,W | Θ)dymis∫
θ
∫
ymis f(θ)f(Y
obs,ymis,W | θ)dymisdθ ; (5)
4. Obtain the posterior predictive distribution of Y mis :
f(Y mis | Y obs,W ) =
∫
θ
f(Y mis | Y obs,W ,θ)f(θ | Y obs,W )dθ, (6)
and the posterior predictive distribution of τ¯l, which is a function of Y
obs and Y mis.
Under the context of randomized controlled 2K factorial designs, the treatment assignment W is
ignorable (Rubin, 1978), implying that we can simplify (4)–(6) by essentially dropping it from the
right hand sides. Moreover, SUTVA implies further simplifications of (4)–(6), as we will show in
the next section.
3.2. Independent potential outcomes model
Following Ding and Dasgupta (2016), we first consider a model with independent potential out-
comes. For all j = 1, . . . , J, let pij = Pr{Yi(zj) = 1} denote the (prior) marginal probabilities of
the potential outcomes. Suppose that the marginal probabilities are independently generated by
Beta(αj , βj), where αj and βj are pre-specified constants. Given pimar = (pi1, . . . , piJ)
′ assume that
the potential outcomes for unit i = 1, . . . , N are generated by
Yi(zj) ∼ Bernoulli(pij) (j = 1, . . . , J); Yi(zj′) ⊥ Yi(zj′′) (j′ 6= j′′). (7)
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As mentioned previously, SUTVA and the completely randomized treatment assignment W enable
us to derive (5) as follows:
f(pimar | Y obs,W ) ∝
J∏
j=1
(pij)
αj−1(1− pij)βj−1
J∏
j=1
(pij)
nobsj (1− pij)nj−nobsj ,
which immediately suggests the following two-step Monte Carlo procedure to sample from the
posterior predictive distribution of the factorial effect τ¯l :
1. Draw pimar from
pij | Y obs,W ind.∼ Beta(αj + nobsj , βj + nj − nobsj ) (j = 1, . . . , J); (8)
2. For all j = 1, . . . , J, let Bj denote the sum of missing potential outcomes for zj . Given the
drawn pimar, draw
Bj | Y obs,W ,pimar ind.∼ Binomial(N − nj , pij), (9)
and therefore
τ¯l | Y obs,W ,pimar ∼ 2−(k−1)N−1
J∑
j=1
hlj(n
obs
j +Bj). (10)
There is a two-fold reason that we consider the independent potential outcomes model as the
first step of applying Rubin (1978)’s finite-population Bayesian causal inference framework to 2K
factorial designs. On the one hand, because of the missing data nature of the potential outcomes
framework (Imbens and Rubin, 2015), the observed data only directly helps us infer the marginal
distributions of but not the associations between the potential outcomes. On the other hand, the
imputation procedure (8)–(10) implies closed-form expressions for the posterior predictive mean
and variance of τ¯l.
Theorem 1. Let n′j = nj + αj + βj and pˆ
′
j = (n
obs
j + αj)/n
′
j for all j = 1, . . . , J. The posterior
predictive mean and variance of τ¯l are
E(τ¯l | Y obs,W ) = 2−(k−1)N−1
J∑
j=1
hlj{nj pˆj + (N − nj)pˆ′j} (11)
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and
Var(τ¯l | Y obs,W ) = 2−2(k−1)
J∑
j=1
N − nj + n′j
N
(
1− nj
N
) pˆ′j(1− pˆ′j)
n′j + 1
, (12)
respectively.
Corollary 1. Assume that αj , βj  nj for all j = 1, . . . , J, then
E(τ¯l | Y obs,W ) ≈ ˆ¯τl (13)
and
Var(τ¯l | Y obs,W ) ≈ 2−2(K−1)
J∑
j=1
(
1− nj
N
) pˆj(1− pˆj)
nj − 1 , (14)
respectively. The approximations become exact as N →∞.
We conclude this section by following Rubin (1984) and evaluating the Frequentist property of
the above Bayesian procedure. Among other things, the following corollary suggests that when the
potential outcomes are independent, the posterior predictive variance of τ¯l in (12) reconciles with
its Frequentist counterpart.
Corollary 2. The posterior predictive variance of the factorial effect τ¯l in (12) is generally smaller
than the Neymanian variance estimator in (3), i.e.,
Var(τ¯l | Y obs,W ) ≤ V̂arNey(ˆ¯τl).
The equality holds if all potential outcomes are pair-wisely unassociated:
Sjj′ = (N − 1)−1
N∑
i=1
{Yi(zj)− pj}{Yi(zj′)− pj′} = 0 (j 6= j′). (15)
3.3. Sensitivity analysis
Despite the apparent theoretical and computational appeals, the aforementioned independent po-
tential outcomes model may be inappropriate in practice, as pointed out by Ding and Dasgupta
(2016). In particular, when the potential outcomes are positively correlated, the resulted Bayesian
credible intervals may under-cover the factorial effect τ¯l. Therefore, even though the marginal dis-
9
tributions of the potential outcomes can be inferred, it is imperative that we take into account
the dependence structure between them, when developing any Bayesian procedures for 2K factorial
designs. To facilitate more in-depth understanding, we discuss the key role that the independence
assumption in (7) plays, before presenting any proposals.
There are two pain-points we wish to emphasize here. First, with or without the independence
assumption, the posterior distribution of the marginal probabilities pimar = (pi1, . . . , piJ)
′ and the
posterior predictive mean of τ¯l remain the same as in (8) and (11), respectively. Second and more
importantly, as mentioned before the crux of Rubin (1978)’s framework is the imputation of the
missing potential outcomes. To be specific, for each i = 1, . . . , N, because there exists only one j
such that Wi(zj) = 1 and Y
obs
i = Yi(zj), we need to impute Yi(zj′) for all j
′ 6= j. This is rather
straightforward under the independence assumption, because as mentioned in the previous section
we can draw the marginal probabilities pimar from (8), and then draw Yi(zj′) ∼ Bernoulli(pij′)
for all j′ 6= j. Unfortunately, however, this strategy no longer works without the independence
assumption, because the value of the observed potential outcome Yi(zj) indeed becomes relevant
when imputing the missing potential outcomes, as pointed out by Ding and Dasgupta (2016). To
be more specific, denote the conditional probabilities
pij′|j=s = Pr{Yi(zj′) = 1 | Yi(zj) = s} (16)
for s = 0, 1. If Yi(zj) = s, the missing potential outcome Yi(zj′) ∼ Bernoulli(pij′|j=s).
Although the conditional probabilities in (16) are crucial in imputing the missing potential
outcomes, they are not identifiable from the observed data, because we cannot jointly observe the
potential outcomes under zj and zj′ . For treatment-control studies, Ding and Dasgupta (2016)
pointed out that the joint distribution of the treatment and control potential outcomes can be
uniquely determined by their marginal distributions and a single association parameter, and pro-
posed to conduct sensitivity analysis by varying the association parameter accordingly. For more
general 2K factorial designs, in principle it is possible to fix the marginal probabilities pimar, and
vary the associations between all the potential outcome pairs. However, because the dependence
structure becomes more complex (Cox, 1972; Teugels, 1990; Dai et al., 2013), it is imperative to
invoke some structural assumptions to make this problem somewhat tractable. From the lengthy
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list of proposals (e.g., Emrich and Piedmonte, 1991; Lee, 1993; Gange, 1995; Park et al., 1996; Kang
and Jung, 2001; Oman and Zucker, 2001; Qaqish, 2003), we adopt the framework by Oman (2009),
who proposed to construct the joint distribution of the potential outcomes such that
Pr{Yi(zj) = 1, Yi(zj′) = 1} = (1− γjj′)pijpij′ + γjj′ min(pij , pij′),
for all j 6= j′, where γjj′ ∈ [0, 1) characterizes the association between the potential outcome pair
Yi(zj) and Yi(zj′). The above suggests that, for any fixed value of γjj′ , we can derive closed-form
expressions for the conditional probabilities in (16).
Theorem 2. Under Oman (2009)’s framework,
pij′|j=1 = (1− γjj′)pij′ + γjj′ min
(
1,
pij′
pij
)
, pij′|j=0 = (1− γjj′)pij′ + γjj′
max(pij′ − pij , 0)
1− pij . (17)
Theorem 2 suggests that, in order to perform the sensitivity analysis, we only need to specify
γjj′ for all j 6= j′, i.e., the pair-wise correlation structure of the potential outcomes. Oman (2009)
proposed several models for such correlation structure. For 22 factorial designs which we focus in
the next two sections, we adopt the AR(1) correlation structure, where we specify the sensitivity
parameter ρ ∈ [0, 1), and for all j 6= j′ let γjj′ = ρ|j−j′|. This appears to be a reasonable assumption
for the dependence structure of the potential outcomes. To be more specific, because the treatment
combinations z1, . . . ,zJ are nonexchangeable by definition, and we are essentially assuming that
the association between Yi(zj) and Yi(zj′) exponentially decays as |j − j′| (i,e., the “distance”
between zj and zj′) increases. However, for more general (i.e., K ≥ 3) factorial designs, we may
need to consider other dependence structures (e.g., Toeplitz matrix, see Chen et al., 2006).
With the help of Theorem 2 and the pair-wise correlation structure of the potential outcomes,
we now formally present the Bayesian sensitivity analysis procedure as follows:
1. Specify the value of the sensitivity parameter ρ;
2. Same as for the independent potential outcomes model, use (8) to draw the marginal proba-
bilities pimar = (pi1, . . . , piJ)
′;
3. For all j = 1, . . . , J, use (17) to calculate the conditional probabilities in (16);
11
4. For all j′ 6= j independently draw
Bj|j′=1 ∼ Binomial(nobsj′ , pij|j′=1), Bj|j′=0 ∼ Binomial(nj′ − nobsj′ , pij|j′=0)
and let
Cj =
∑
j′ 6=j
1∑
s=0
Bj|j′=s
denote the sum of missing potential outcomes for zj . Therefore
τ¯l | Y obs,W ,pimar ∼ 2−(k−1)N−1
J∑
j=1
hlj(n
obs
j + Cj).
For fixed value of the sensitivity parameter γ, when closed-form expressions for the posterior
predictive mean and variance of τ¯l are infeasible, we use Monte Carlo methods for approximation.
As suggested by Ding and Dasgupta (2016), in practice we can vary ρ over a wide range of values
(e.g., from zero to one), and repeat the above Monte Carlo procedure for each value. In the next
two sections, we provide several simulated and empirical examples for illustration.
4. SIMULATION STUDIES
In this section, we conduct simulation studies to examine the Neymanian variance estimator in (3)
and the posterior predictive variance under independence assumption in (12).
To mimic the empirical examples in the next section, consider a balanced 22 factorial design
with N = 800 experimental units, so that (n1, n2, n3, n4) = (200, 200, 200, 200). To save space for
the main text, we focus on τ¯1. We generate 100 simulation cases by repeatedly drawing from the
following hierarchical model:
Uj
iid.∼ Unif(0, 1) (j = 1, . . . , 16); τ = (U1, . . . , U16)′
/ 16∑
j=1
Uj ,
and
D = (D0,0,...,0, . . . , D1,1,...,1)
′ | τ ∼ Multinomial(800, τ ).
We report details of the simulation cases in Appendix B.1, so that the readers can replicate our
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simulation results. For each case, we first calculate the factorial effect τ¯1. Second, independently
draw 500 treatment assignments and the corresponding observed data. Third, For each observed
dataset, use (1), (3) and (12) to calculate the point estimate ˆ¯τ1, its Neymanian variance estimates,
and the posterior predictive variance of τ¯1 under the independence assumption, respectively. Fourth,
construct the 95% Neymanian confidence intervals and “independent” Bayesian credible interval.
Figure 1 contains the coverage rates of the intervals. The Neymanian interval generally over-
covers τ¯1, with coverage rates greater than 0.96 for 100% of the cases. Second, the independent
Bayesian interval manages to correct the over-coverage of the Neymanian interval, with coverage
rates greater than 0.96 for only 9% of the cases. However, for 11% of the cases it under-covers
with coverage rates smaller than 0.94, suggesting that the proposed Bayesian sensitivity analysis is
indeed necessary.
To more thoroughly demonstrate the characteristic of the Bayesian interval, in Appendix B.2
we conduct a new set of simulation studies.
5. EMPIRICAL EXAMPLE
We re-analyze a randomized controlled 22 factorial design which evaluated the factorial effects of
nicotine gum consumption (2gm/day vs. placebo) and counseling (health education vs. motiva-
tional interviewing) on N = 755 African American light smokers. For details of the study, see
Ahluwalia et al. (2006). The primary outcome of the study is whether participants quit smok-
ing 26 weeks after enrollment, and the observed data is (n1, n2, n3, n4) = (189, 188, 189, 189) and
(nobs1 , n
obs
2 , n
obs
3 , n
obs
4 ) = (13, 29, 19, 34).
To save space for the main text, we only focus on τ¯2. We report the results in Figure 2, from
which we can draw several conclusions. First, from a Neymanian perspective, ˆ¯τ2 = 0.082 and the
corresponding 95% confidence interval is (0.035, 0.129). Second, the independence Bayesian interval
is (0.041, 0.123), which is 14% narrower than the Neymanian interval. Third, the sensitivity analysis
suggests that the widest Bayesian interval is (0.037, 0.125), where ρ = 0.68. In other words, this
is our most “conservative” Bayesian interval without knowing the underlying correlation between
the potential outcomes.
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Figure 1: Simulation results: The horizontal axis represents the case index, and the vertical shows
the coverage rates for the 95% Neymanian (rectangular) and independent Bayesian (triangular)
intervals.
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Figure 2: Empirical results for Ahluwalia et al. (2006)’s data-set: the Neymanian, “independent”
Bayesian and “conservative” Bayesian point and interval estimates.
6. CONCLUDING REMARKS
To address the (sometimes severe) variance over-estimation issue of the classic Neymanian causal
inference framework, this paper extended Rubin (1978)’s and Ding and Dasgupta (2016)’s finite-
population Bayesian inference framework to 2K factorial designs with binary outcomes. As em-
phasized by Rubin (1978), the crux of the finite-population Bayesian framework is the imputation
of the missing potential outcomes. Because the potential outcomes cannot be jointly observed, we
first developed an imputation model under the assumption that they are independent given their
marginal probabilities. To assess how violations of the independence assumption impacted our
analysis, we proposed a novel sensitivity analysis procedure. To demonstrate the advantages of our
proposed methodology, we provided several simulated and empirical examples.
Our work suggests multiple future directions. First, we can generalize our current framework
to more complex experiment settings, such as 3k or fractional factorial designs, and cross-over
designs. Second, it is possible to extend our framework to accommodate more general outcomes,
such as continuous or time to event. Third, while developing Bayesian procedures is important,
it might also be desirable to sharpen the existing Neymanian inference for 2K factorial designs.
For treatment-control studies, Ding and Dasgupta (2016) and Aronow et al. (2014) proposed the
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respective “improved” Neymanian variance estimators, by deriving sharp lower bounds for the
individual-level treatment effect variation. Unfortunately, however, extending their results to 2K
factorial designs might not be a trivial task, because of the the complex dependence structure of
the potential outcomes. Fourth, we can incorporate pre-treatment covariate information into our
current framework, especially for developing alternative sensitivity analysis procedures. We leave
the above for future research.
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A. PROOFS OF LEMMAS, THEOREMS AND COROLLARIES
Proof of Theorem 1. The proof largely follow that of Ding and Dasgupta (2016)’s Theorem 2. To
be specific, by (8)
E(pij | Y obs,W ) = pˆ′j , Var(pij | Y obs,W ) =
pˆ′j(1− pˆ′j)
n′j + 1
, (18)
and therefore
E{pij(1− pij) | Y obs,W } =
n′j
n′j + 1
pˆ′j(1− pˆ′j). (19)
With the help of (18)–(19), we can now prove Theorem 1. First, by (9), (10) and (18)
E(τ¯l | Y obs,W ) = E{E(τ¯l | Y obs,W ,pimar) | Y obs,W }
= 2−(k−1)N−1
J∑
j=1
hlj{nobsj + (N − nj)E(pij | Y obs,W )}
= 2−(k−1)N−1
J∑
j=1
hlj{nj pˆj + (N − nj)pˆ′j}.
Second, by (9), (10) and (19)
E{Var(τ¯l | Y obs,W ,pimar) | Y obs,W } = 2−2(k−1)N−2
J∑
j=1
(N − nj)E{pij(1− pij) | Y obs,W }
= 2−2(k−1)N−2
J∑
j=1
(N − nj)n′j
n′j + 1
pˆ′j(1− pˆ′j),
and
Var{E(τ¯l | Y obs,W ,pimar) | Y obs,W } = 2−2(k−1)N−2
J∑
j=1
Var

J∑
j=1
hlj(N − nj)pij | Y obs,W

= 2−2(k−1)N−2
J∑
j=1
(N − nj)2pˆ′j(1− pˆ′j)
n′j + 1
.
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Consequently,
Var(τ¯l | Y obs,W ) = E{Var(τ¯l | Y obs,W ,pimar) | Y obs,W }+ Var{E(τ¯l | Y obs,W ,pimar) | Y obs,W }
= 2−2(k−1)
J∑
j=1
N − nj + n′j
N
(
1− nj
N
) pˆ′j(1− pˆ′j)
n′j + 1
.
The proof is complete.
Proof of Corollary 1. Because αj , βj  nj for j = 1, . . . , J,
pˆ′j =
nobsj + αj
nj + αj + βj
≈ pˆj
and
N − nj + n′j
N
= 1 +
αj + βj
N
≈ 1.
Therefore, by (1) and (11),
E(τ¯l | Y obs,W ) = 2−(k−1)N−1
J∑
j=1
hlj{nj pˆj + (N − nj)pˆ′j}
≈ 2−(k−1)
J∑
j=1
hlj pˆj
= ˆ¯τl.
Similarly, by (12),
Var(τ¯l | Y obs,W ) = 2−2(k−1)
J∑
j=1
N − nj + n′j
N
(
1− nj
N
) pˆ′j(1− pˆ′j)
n′j + 1
≈ 2−2(k−1)
J∑
j=1
(
1− nj
N
) pˆj(1− pˆj)
nj − 1 .
The proof is complete.
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Proof of Corollary 2. The first part is obvious by (3), (12), and the fact that
1− nj
N
≤ 1 (j = 1, . . . , J).
Moreover, the definition of ˆ¯τl in (1) suggests that
VarNey(ˆ¯τl) = 2
−2(K−1)

J∑
j=1
VarNey(pˆj) +
∑
j 6=j′
hljhlj′CovNey(pˆj , pˆj′)

= 2−2(K−1)

J∑
j=1
(
1
nj
− 1
N
)
S2j −
1
N
∑
j 6=j′
hljhlj′Sjj′

= 2−2(K−1)
J∑
j=1
(
1
nj
− 1
N
)
S2j .
The last step holds because of (15). Therefore, the corresponding
V̂arNey(ˆ¯τl) = 2
−2(K−1)
J∑
j=1
(
1
nj
− 1
N
)
s2j
= 2−2(K−1)
J∑
j=1
(
1− nj
N
) pˆj(1− pˆj)
nj − 1 ,
which completes the proof.
Proof of Theorem 2. Because
Pr{Yi(zj) = 1, Yi(zj′) = 1} = (1− γjj′)pijpij′ + γjj′ min(pij , pij′),
we have
pij′|j=1 =
Pr{Yi(zj′) = 1, Yi(zj) = 1}
Pr{Yi(zj) = 1}
=
(1− γjj′)pijpij′ + γjj′ min(pij , pij′)
pij
= (1− γjj′)pij′ + γjj′ min
(
1,
pij′
pij
)
,
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and
pij′|j=0 =
Pr{Yi(zj′) = 1, Yi(zj) = 0}
Pr{Yi(zj) = 0}
=
Pr{Yi(zj′) = 1} − Pr{Yi(zj′) = 1, Yi(zj) = 1}
1− Pr{Yi(zj) = 1}
=
pij′ − (1− γjj′)pijpij′ − γjj′ min(pij , pij′)
1− pij
=
(1− γjj′)(1− pij)pij′ + γjj′pij′ − γjj′ min(pij , pij′)
1− pij
= (1− γjj′)pij′ + γjj′
max(pij′ − pij , 0)
1− pij .
The proof is complete.
B. ADDITIONAL INFORMATION OF THE SIMULATED AND
EMPIRICAL EXAMPLES
B.1. Details of the simulation cases
We report the 100 simulation cases in the following three tables:
• Table 1, Cases 1–33:
24
Case (D0,0,...,0;D0,0,...,1; . . . , D1,1,...,0;D1,1,...,1)
1 (33, 12, 0, 63, 18, 93, 63, 118, 53, 41, 44, 71, 67, 58, 58, 8)
2 (52, 61, 10, 57, 111, 64, 22, 25, 11, 67, 85, 39, 7, 107, 57, 25)
3 (30, 79, 46, 26, 103, 31, 94, 130, 29, 9, 75, 1, 50, 34, 42, 21)
4 (50, 140, 0, 73, 22, 58, 0, 93, 128, 23, 22, 10, 3, 51, 93, 34)
5 (61, 47, 89, 91, 92, 49, 30, 7, 46, 50, 9, 24, 7, 66, 22, 110)
6 (51, 70, 58, 89, 32, 6, 59, 98, 7, 77, 43, 65, 113, 0, 27, 5)
7 (11, 118, 61, 54, 23, 24, 5, 77, 62, 15, 110, 34, 76, 8, 8, 114)
8 (66, 16, 73, 49, 75, 26, 34, 24, 23, 28, 74, 92, 88, 29, 52, 51)
9 (17, 71, 35, 45, 55, 16, 23, 25, 3, 87, 106, 64, 90, 80, 65, 18)
10 (21, 100, 37, 11, 105, 99, 5, 1, 99, 20, 74, 30, 18, 18, 55, 107)
11 (62, 55, 54, 48, 60, 36, 60, 55, 67, 80, 36, 24, 23, 48, 43, 49)
12 (50, 59, 95, 15, 8, 0, 65, 32, 69, 29, 67, 46, 57, 93, 60, 55)
13 (36, 99, 70, 68, 15, 97, 2, 28, 20, 75, 70, 73, 0, 34, 32, 81)
14 (84, 65, 66, 5, 70, 23, 7, 24, 2, 71, 93, 19, 62, 40, 93, 76)
15 (86, 107, 17, 106, 14, 30, 74, 19, 11, 64, 50, 3, 41, 12, 92, 74)
16 (14, 29, 38, 123, 11, 33, 18, 46, 65, 41, 12, 115, 112, 21, 24, 98)
17 (27, 61, 47, 35, 13, 83, 44, 56, 88, 66, 24, 52, 22, 57, 54, 71)
18 (10, 7, 65, 75, 1, 63, 64, 79, 33, 103, 60, 23, 63, 76, 13, 65)
19 (34, 10, 92, 21, 2, 72, 93, 7, 51, 65, 44, 65, 70, 64, 73, 37)
20 (25, 102, 88, 54, 57, 75, 14, 31, 96, 19, 26, 48, 71, 92, 2, 0)
21 (8, 61, 78, 40, 35, 85, 75, 78, 49, 0, 64, 52, 41, 39, 23, 72)
22 (48, 79, 87, 28, 28, 6, 52, 53, 75, 20, 71, 29, 49, 18, 87, 70)
23 (41, 18, 62, 35, 1, 74, 51, 62, 27, 82, 47, 78, 91, 64, 52, 15)
24 (57, 46, 62, 36, 42, 26, 109, 24, 71, 58, 33, 69, 34, 37, 58, 38)
25 (27, 52, 47, 18, 5, 89, 111, 6, 7, 66, 17, 110, 75, 18, 55, 97)
26 (97, 30, 101, 29, 24, 1, 11, 0, 9, 53, 104, 43, 20, 91, 79, 108)
27 (74, 31, 77, 24, 21, 21, 98, 67, 67, 95, 54, 6, 19, 76, 39, 31)
28 (80, 83, 22, 41, 65, 10, 77, 30, 63, 57, 58, 46, 55, 57, 33, 23)
29 (60, 85, 64, 14, 10, 99, 57, 57, 4, 34, 35, 91, 61, 14, 61, 54)
30 (55, 83, 104, 37, 1, 99, 32, 21, 2, 78, 18, 27, 63, 10, 47, 123)
31 (26, 26, 47, 103, 55, 2, 13, 84, 49, 104, 62, 16, 80, 33, 42, 58)
32 (18, 116, 79, 61, 9, 41, 13, 23, 28, 72, 20, 60, 43, 66, 77, 74)
33 (65, 68, 61, 8, 38, 53, 52, 74, 7, 71, 0, 57, 47, 49, 82, 68)
25
• Table 2, Cases 34–66:
Case (D0,0,...,0;D0,0,...,1; . . . , D1,1,...,0;D1,1,...,1)
34 (15, 61, 73, 18, 58, 9, 31, 101, 89, 78, 56, 76, 20, 56, 34, 25)
35 (91, 20, 10, 66, 24, 91, 0, 50, 100, 69, 55, 101, 38, 4, 44, 37)
36 (27, 8, 47, 71, 96, 29, 88, 23, 73, 23, 78, 13, 66, 82, 0, 76)
37 (66, 88, 60, 24, 105, 8, 0, 2, 59, 2, 74, 69, 68, 55, 21, 99)
38 (1, 67, 10, 74, 75, 55, 85, 63, 20, 55, 54, 20, 45, 80, 65, 31)
39 (70, 3, 63, 45, 110, 36, 36, 32, 62, 2, 36, 17, 59, 77, 69, 83)
40 (69, 6, 62, 25, 43, 58, 42, 73, 33, 64, 40, 57, 39, 52, 65, 72)
41 (81, 64, 16, 13, 78, 66, 55, 58, 63, 57, 28, 83, 33, 27, 46, 32)
42 (91, 28, 15, 0, 106, 75, 2, 113, 75, 70, 8, 18, 57, 92, 48, 2)
43 (46, 57, 51, 99, 97, 108, 5, 55, 5, 25, 43, 21, 81, 36, 17, 54)
44 (28, 29, 25, 83, 77, 52, 86, 75, 78, 33, 43, 4, 16, 33, 62, 76)
45 (39, 74, 55, 44, 0, 4, 24, 97, 60, 6, 70, 37, 64, 38, 80, 108)
46 (48, 23, 120, 64, 24, 17, 26, 101, 9, 34, 134, 6, 112, 35, 9, 38)
47 (69, 67, 35, 29, 87, 44, 75, 49, 30, 15, 12, 89, 56, 14, 69, 60)
48 (96, 17, 33, 34, 47, 66, 73, 40, 14, 71, 78, 35, 99, 4, 82, 11)
49 (39, 14, 28, 11, 64, 67, 37, 53, 85, 55, 62, 53, 78, 30, 98, 26)
50 (61, 38, 73, 78, 27, 40, 24, 78, 21, 61, 67, 45, 59, 27, 31, 70)
51 (50, 56, 39, 66, 97, 25, 96, 24, 46, 38, 12, 12, 79, 66, 83, 11)
52 (98, 7, 24, 66, 22, 57, 0, 20, 51, 116, 27, 38, 74, 95, 75, 30)
53 (115, 38, 15, 53, 62, 94, 30, 55, 37, 62, 30, 8, 84, 76, 0, 41)
54 (45, 81, 75, 70, 41, 39, 71, 35, 21, 9, 11, 78, 71, 1, 87, 65)
55 (11, 57, 41, 74, 86, 45, 81, 89, 66, 59, 63, 18, 0, 62, 12, 36)
56 (16, 68, 93, 62, 67, 55, 92, 23, 31, 88, 4, 1, 89, 17, 56, 38)
57 (72, 50, 94, 24, 101, 101, 26, 78, 50, 32, 48, 44, 17, 42, 15, 6)
58 (8, 50, 2, 88, 99, 48, 23, 93, 39, 77, 66, 102, 56, 11, 32, 6)
59 (53, 39, 23, 68, 46, 69, 77, 90, 10, 68, 44, 61, 17, 46, 39, 50)
60 (22, 28, 51, 86, 63, 76, 49, 43, 55, 88, 44, 10, 5, 84, 65, 31)
61 (66, 71, 15, 109, 36, 34, 111, 33, 21, 9, 22, 30, 52, 52, 79, 60)
62 (69, 53, 102, 43, 44, 8, 90, 4, 18, 90, 0, 85, 10, 42, 73, 69)
63 (39, 74, 94, 66, 61, 56, 30, 47, 37, 3, 25, 48, 17, 117, 59, 27)
64 (91, 42, 75, 85, 1, 79, 11, 28, 99, 20, 73, 20, 20, 2, 106, 48)
65 (46, 97, 55, 99, 67, 87, 4, 79, 7, 75, 7, 57, 21, 25, 3, 71)
66 (46, 56, 47, 32, 10, 15, 68, 36, 85, 39, 25, 62, 61, 106, 18, 94)
26
• Table 3, Cases 67–100:
Case (D0,0,...,0;D0,0,...,1; . . . , D1,1,...,0;D1,1,...,1)
67 (67, 23, 32, 45, 71, 18, 85, 75, 37, 21, 2, 65, 102, 35, 45, 77)
68 (76, 53, 65, 3, 53, 116, 72, 40, 7, 32, 9, 21, 40, 84, 65, 64)
69 (37, 48, 41, 68, 69, 59, 41, 71, 61, 44, 22, 58, 71, 37, 49, 24)
70 (63, 75, 69, 5, 72, 61, 25, 68, 75, 56, 23, 9, 92, 22, 41, 44)
71 (64, 18, 60, 78, 20, 21, 51, 112, 7, 72, 51, 39, 51, 63, 23, 70)
72 (44, 43, 30, 62, 81, 112, 43, 75, 56, 3, 6, 43, 91, 68, 0, 43)
73 (67, 3, 12, 11, 38, 10, 83, 72, 84, 49, 63, 83, 75, 74, 13, 63)
74 (44, 23, 52, 28, 7, 18, 77, 82, 59, 76, 94, 58, 74, 25, 53, 30)
75 (13, 20, 52, 3, 64, 21, 53, 63, 35, 53, 31, 73, 64, 77, 89, 89)
76 (68, 24, 22, 13, 87, 68, 20, 59, 78, 13, 50, 98, 59, 37, 29, 75)
77 (60, 35, 73, 59, 25, 11, 91, 20, 43, 6, 103, 6, 89, 59, 26, 94)
78 (47, 70, 84, 18, 19, 62, 69, 30, 46, 33, 72, 70, 71, 14, 62, 33)
79 (83, 32, 64, 64, 24, 22, 14, 58, 51, 51, 68, 50, 66, 68, 65, 20)
80 (14, 78, 75, 2, 52, 54, 12, 65, 32, 34, 51, 84, 59, 41, 79, 68)
81 (63, 77, 51, 59, 97, 40, 34, 102, 78, 102, 2, 8, 15, 23, 20, 29)
82 (48, 14, 45, 64, 65, 39, 55, 76, 90, 72, 48, 50, 62, 46, 6, 20)
83 (85, 27, 63, 76, 41, 71, 54, 60, 10, 40, 18, 67, 26, 72, 60, 30)
84 (66, 22, 96, 31, 76, 5, 51, 51, 28, 26, 30, 93, 66, 93, 14, 52)
85 (10, 93, 45, 4, 86, 50, 63, 65, 77, 80, 59, 32, 38, 12, 8, 78)
86 (68, 75, 26, 18, 4, 47, 70, 43, 91, 76, 98, 18, 57, 2, 37, 70)
87 (49, 77, 73, 80, 69, 78, 2, 1, 62, 42, 26, 71, 2, 80, 23, 65)
88 (84, 87, 39, 7, 74, 13, 104, 28, 51, 28, 24, 56, 65, 75, 32, 33)
89 (68, 39, 90, 44, 87, 8, 63, 62, 5, 82, 82, 8, 85, 11, 25, 41)
90 (64, 23, 75, 52, 15, 95, 33, 80, 79, 57, 70, 2, 13, 52, 21, 69)
91 (85, 96, 6, 34, 17, 1, 5, 9, 77, 101, 65, 71, 55, 60, 71, 47)
92 (22, 58, 58, 89, 76, 74, 92, 72, 37, 20, 12, 24, 87, 9, 32, 38)
93 (74, 100, 7, 87, 19, 58, 33, 48, 13, 86, 37, 7, 55, 65, 74, 37)
94 (85, 54, 29, 70, 83, 50, 47, 55, 67, 48, 21, 0, 17, 70, 63, 41)
95 (31, 47, 6, 13, 62, 70, 77, 91, 60, 59, 0, 87, 23, 93, 58, 23)
96 (7, 37, 61, 21, 84, 93, 79, 56, 91, 58, 1, 45, 22, 74, 16, 55)
97 (43, 34, 60, 36, 72, 21, 38, 46, 71, 45, 34, 38, 69, 61, 56, 76)
98 (26, 90, 155, 16, 78, 34, 0, 33, 30, 76, 6, 58, 113, 25, 35, 25)
99 (40, 8, 79, 10, 71, 42, 33, 12, 31, 78, 89, 61, 60, 59, 58, 69)
100 (17, 27, 84, 54, 95, 13, 54, 8, 32, 68, 53, 32, 19, 96, 56, 92)
B.2. Additional simulation studies
To examine the performance of the Bayesian interval under more settings, we extend Section 4 and
consider a imbalanced 22 factorial design with (n1, n2, n3, n4) = (150, 150, 250, 250). Again we focus
on τ¯1, and repeat the same practice in Section 4 by generating and analyzing 100 simulation cases.
For brevity we omit reporting the simulation cases.
We plot the coverage rates in Figure 3. Again, the Neymanian interval generally over-covers τ¯1.
The independent Bayesian interval manages to correct the over-coverage of the Neymanian interval
and sometimes slightly under-covers, implying the need of sensitivity analysis.
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Figure 3: Additional simulation results: The horizontal axis represents the case index, and the
vertical shows the coverage rates for the 95% Neymanian (rectangular) and independent Bayesian
(triangular) intervals.
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